Toxicogenomics Study on TK6 Human Lymphoblast Cells Treated with Mitomycin C |
Kim, Joo-Hwan
(Department of Toxicological Researches, National Institute of Toxicological Research, Korea Food and Drug Administration)
Koo, Ye-Mo (Department of Toxicological Researches, National Institute of Toxicological Research, Korea Food and Drug Administration) Lee, Woo-Sun (Department of Toxicological Researches, National Institute of Toxicological Research, Korea Food and Drug Administration) Suh, Soo-Kyung (Department of Toxicological Researches, National Institute of Toxicological Research, Korea Food and Drug Administration) Kang, Jin-Seok (Department of Toxicological Researches, National Institute of Toxicological Research, Korea Food and Drug Administration) Han, Eui-Sik (Department of Toxicological Researches, National Institute of Toxicological Research, Korea Food and Drug Administration) Kim, Seung-Hee (Department of Toxicological Researches, National Institute of Toxicological Research, Korea Food and Drug Administration) Park, Sue-N. (Department of Toxicological Researches, National Institute of Toxicological Research, Korea Food and Drug Administration) |
1 | Tennant, R. A. The National Center for toxicogenomics: using new technologies to inform mechanistic toxicology. Environ Health Perspect 107:A256-A258 (2002) DOI |
2 | Cheung, R. Y., Rauth, A. M. & Wu Yu. In vivo efficacy and toxicity of intratumorally delivered mitomycin C and its combination with doxorubicin using microsphere formulations. Anticancer Drugs 16:423-433 (2005) DOI ScienceOn |
3 | Joseph, P., Xu, Y. & Jaiswal, A. K. Non-enzymatic and enzymatic activation of mitomycin C: identification of a unique cytosolic activitiy. Int J Cancer 65: 263-271 (1996) DOI |
4 | Aardema, M. J. & MacGregor, J. T. Toxicology and genetic toxicology in the new era of 'toxicogenomics'; impact of '-omics' technologies. Mutat Res 499:13-25 (2002) DOI ScienceOn |
5 | Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell 88:323-331 (1997) DOI ScienceOn |
6 | Zhu, K. Q. & Zhang, S. J. Involvement of ATM/ATR-p38 MAPK cascade in MNNG induced G1-S arrest. World J Gastroenterol 9:2073-2077 (2003) DOI |
7 | Palom, Y. et al. Structure of adduct X, the last unknown of the six major DNA adducts of mitomycin C formed in EMT6 mouse mammary tumor cells. Chem Res Toxicol 13:479-488 (2000) DOI ScienceOn |
8 | Kastan, M. B. et al. Participationg of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304-6311 (1991) |
9 | Hess, R. et al. Nuclear accumulation of p53 in response to treatment with DNA-damaging agents. Toxicol Lett 72:43-52 (1994) DOI ScienceOn |
10 | van Delft, J. M. H. et al. Discrimination of genotoxic from non-genotoxic carcinogen by gene expression profiling. Carcinogenesis 25:1265-1276 (2004) DOI ScienceOn |
11 | Wilhelm, D., Bender, K., Knebel, A. & Angel, P. The level of intracellular glutathione is a key regulator for the induction of stress-activated signal transduction pathways including Jun N-terminal protein kinases and p38 kinase by alkylating agents. Mol Cell Biol 17:4792-4800 (1997) DOI |
12 | Newton, R. K., Aaraderma, M. & Aubrecht, J. The utility of DNA microarrays for characterizing genotoxicity. Environ Health Perspect 112:420-422 (2004) DOI ScienceOn |